Press Announcing a ground breaking collaboration of Lipidnanoparticles industry experts...
Contract Pharma | Pharma Matters Q&A interview with our CEO, Jarlath Keating
A conversation with Jarlath Keating, CEO of Phosphorex, on the future of LNPs in pharmaceutical innovation.
In recent years, lipid nanoparticles (LNPs) have emerged as a groundbreaking technology in the pharmaceutical world, revolutionizing the delivery of complex therapeutic molecules like RNA and DNA.
The 4th LNP Formulation & Process Development Summit returns to Boston, as the only industry summit dedicated to unveiling the hottest pre-clinical and clinical data, overcoming the greatest challenges within the LNP IP space and uncovering the most innovative LNP formulations for extrahepatic delivery of cell therapies, gene therapies, mRNA therapeutics and beyond!
Join ASGCT in New Orleans, May 13-17, 2025 for the premier event in cell and gene therapy, the ASGCT 28th Annual Meeting!
The BIO International Convention is the largest and most comprehensive event for biotechnology, representing the full ecosystem of biotech with 20,000 industry leaders from across the globe.
Whether you work at a public pharmaceutical company, biotech startup, academia, non-profits, and government or are a researcher, business development professional or investor, BIO is where you'll make valuable connections and build relationships. Our proprietary BIO One-on-One Partnering™ match-making platform—included in the Premier Access registration package—allows you to find potential partners, schedule and accept meetings.
Uniting North American biopharma decision-makers to innovate at speed, equipping them with the critical intelligence & partners they require to make informed pipeline decisions in early-stage R&D.